Abstract
A substantial body of literature highlights the challenges that exist providing palliative and end-of-life care for people with a hematological malignancy. This group of patients commonly (1) receive aggressive care close to the end of life
(such as chemotherapy administration, emergency admissions, intensive care unit admissions); (2) die in hospital; and (3) have palliative care integrated later and less often compared to their solid tumor counterparts. Among other issues, a significant problem is reported to be difficulties in accurately predicting mortality at the end of life for these patients due to a fluctuating and unpredictable illness trajectory. There can often be potential for cure in the face of critical illness or advanced disease. People with a hematological malignancy who are nearing the end of their life can experience a swift change in the goals
of care from curative or life prolonging, to palliative.
(such as chemotherapy administration, emergency admissions, intensive care unit admissions); (2) die in hospital; and (3) have palliative care integrated later and less often compared to their solid tumor counterparts. Among other issues, a significant problem is reported to be difficulties in accurately predicting mortality at the end of life for these patients due to a fluctuating and unpredictable illness trajectory. There can often be potential for cure in the face of critical illness or advanced disease. People with a hematological malignancy who are nearing the end of their life can experience a swift change in the goals
of care from curative or life prolonging, to palliative.
Original language | English |
---|---|
Pages (from-to) | 802-803 |
Number of pages | 2 |
Journal | Journal of Palliative Medicine |
Volume | 20 |
Issue number | 8 |
DOIs | |
Publication status | Published - Aug 2017 |
Externally published | Yes |
Keywords
- Palliative Mortality
- Hematological Malignancy
- Prediction Tools